Presentation is loading. Please wait.

Presentation is loading. Please wait.

Relation of Antiphospholipid Antibodies to Postmortem Brain Infarcts in Older PeopleCLINICAL PERSPECTIVE by Zoe Arvanitakis, Robin L. Brey, Jacob H. Rand,

Published byBetty Ray Modified over 8 years ago

Similar presentations

Presentation on theme: "Relation of Antiphospholipid Antibodies to Postmortem Brain Infarcts in Older PeopleCLINICAL PERSPECTIVE by Zoe Arvanitakis, Robin L. Brey, Jacob H. Rand,"— Presentation transcript:

1 Relation of Antiphospholipid Antibodies to Postmortem Brain Infarcts in Older PeopleCLINICAL PERSPECTIVE by Zoe Arvanitakis, Robin L. Brey, Jacob H. Rand, Julie A. Schneider, Ana W. Capuano, Lei Yu, Sue E. Leurgans, David A. Bennett, and Steven R. Levine Circulation Volume 131(2):182-189 January 13, 2015 Copyright © American Heart Association, Inc. All rights reserved.

2 Number of subjects with overall antiphospholipid antibodies (aPLs) at baseline by overall aPLs proximate to death. Zoe Arvanitakis et al. Circulation. 2015;131:182-189 Copyright © American Heart Association, Inc. All rights reserved.

3 Proportion of subjects with antiphospholipid antibodies (aPLs) at baseline (BL) by aPLs proximate to death. aCL indicates anticardiolipin; anti-β2GPI, anti–β2-glycoprotein I; aPS, anti- phosphatidyl-serine antibodies; and LA, lupus anticoagulant. Zoe Arvanitakis et al. Circulation. 2015;131:182-189 Copyright © American Heart Association, Inc. All rights reserved.

Download ppt "Relation of Antiphospholipid Antibodies to Postmortem Brain Infarcts in Older PeopleCLINICAL PERSPECTIVE by Zoe Arvanitakis, Robin L. Brey, Jacob H. Rand,"

Similar presentations

Detection of antibody-mediated reduction of annexin A5 anticoagulant activity in plasmas of patients with the antiphospholipid syndrome by Jacob H. Rand,

Detection of antibody-mediated reduction of annexin A5 anticoagulant activity in plasmas of patients with the antiphospholipid syndrome by Jacob H. Rand,
SORVEGLIANZA DELLE MALATTIE NEOPLASTICHE. Cancer statistics, 2013 CA: A Cancer Journal for Clinicians Volume 63, Issue 1, pages 11-30, 17 JAN 2013 DOI:

SORVEGLIANZA DELLE MALATTIE NEOPLASTICHE. Cancer statistics, 2013 CA: A Cancer Journal for Clinicians Volume 63, Issue 1, pages 11-30, 17 JAN 2013 DOI:
Trends in Hospitalizations and Outcomes for Acute Cardiovascular Disease and Stroke, 1999–2011CLINICAL PERSPECTIVE by Harlan M. Krumholz, Sharon-Lise T.

Trends in Hospitalizations and Outcomes for Acute Cardiovascular Disease and Stroke, 1999–2011CLINICAL PERSPECTIVE by Harlan M. Krumholz, Sharon-Lise T.
Cumulative Radiation Exposure and Cancer Risk Estimation in Children With Heart DiseaseCLINICAL PERSPECTIVE by Jason N. Johnson, Christoph P. Hornik, Jennifer.

Cumulative Radiation Exposure and Cancer Risk Estimation in Children With Heart DiseaseCLINICAL PERSPECTIVE by Jason N. Johnson, Christoph P. Hornik, Jennifer.
Date of download: 9/17/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Antiphospholipid Antibodies and Subsequent Thrombo-occlusive.

Date of download: 9/17/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Antiphospholipid Antibodies and Subsequent Thrombo-occlusive.
Increased Risk for Heart Valve Disease Associated With Antiphospholipid Antibodies in Patients With Systemic Lupus ErythematosusClinical Perspective by.

Increased Risk for Heart Valve Disease Associated With Antiphospholipid Antibodies in Patients With Systemic Lupus ErythematosusClinical Perspective by.
Catheter Ablation of Atrial Fibrillation by Roderick Tung, Eric Buch, and Kalyanam Shivkumar Circulation Volume 126(2):223-229 July 10, 2012 Copyright.

Catheter Ablation of Atrial Fibrillation by Roderick Tung, Eric Buch, and Kalyanam Shivkumar Circulation Volume 126(2): July 10, 2012 Copyright.
Early Outcomes of Tricuspid Valve Replacement in Young Children by Heather L. Bartlett, Dianne L. Atkins, Trudy L. Burns, Kelly J. Engelkes, Sarah J. Powell,

Early Outcomes of Tricuspid Valve Replacement in Young Children by Heather L. Bartlett, Dianne L. Atkins, Trudy L. Burns, Kelly J. Engelkes, Sarah J. Powell,
Bariatric Surgery and Cardiovascular Risk Factors by Paul Poirier, Marc-André Cornier, Theodore Mazzone, Sasha Stiles, Susan Cummings, Samuel Klein, Peter.

Bariatric Surgery and Cardiovascular Risk Factors by Paul Poirier, Marc-André Cornier, Theodore Mazzone, Sasha Stiles, Susan Cummings, Samuel Klein, Peter.
Omega-3 Fatty Acid Blood Levels by H. Robert Superko, Scott M. Superko, Khurram Nasir, Arthur Agatston, and Brenda C. Garrett Circulation Volume 128(19):2154-2161.

Omega-3 Fatty Acid Blood Levels by H. Robert Superko, Scott M. Superko, Khurram Nasir, Arthur Agatston, and Brenda C. Garrett Circulation Volume 128(19):
Guide to the Assessment of Physical Activity: Clinical and Research Applications by Scott J. Strath, Leonard A. Kaminsky, Barbara E. Ainsworth, Ulf Ekelund,

Guide to the Assessment of Physical Activity: Clinical and Research Applications by Scott J. Strath, Leonard A. Kaminsky, Barbara E. Ainsworth, Ulf Ekelund,
Admission Glucose and Mortality in Elderly Patients Hospitalized With Acute Myocardial Infarction by Mikhail Kosiborod, Saif S. Rathore, Silvio E. Inzucchi,

Admission Glucose and Mortality in Elderly Patients Hospitalized With Acute Myocardial Infarction by Mikhail Kosiborod, Saif S. Rathore, Silvio E. Inzucchi,
The Global Cardiovascular Risk TransitionClinical Perspective by Goodarz Danaei, Gitanjali M. Singh, Christopher J. Paciorek, John K. Lin, Melanie J. Cowan,

The Global Cardiovascular Risk TransitionClinical Perspective by Goodarz Danaei, Gitanjali M. Singh, Christopher J. Paciorek, John K. Lin, Melanie J. Cowan,
Can Adenosine 5′-Triphosphate Be Used to Select Treatment in Severe Vasovagal Syndrome? by Daniel Flammang, Timothy Church, Marc Waynberger, Annick Chassing,

Can Adenosine 5′-Triphosphate Be Used to Select Treatment in Severe Vasovagal Syndrome? by Daniel Flammang, Timothy Church, Marc Waynberger, Annick Chassing,
Endogenous Marinobufagenin-like Immunoreactive Factor and Na +,K + ATPase Inhibition During Voluntary Hypoventilation by Alexei Y. Bagrov, Olga V. Fedorova,

Endogenous Marinobufagenin-like Immunoreactive Factor and Na +,K + ATPase Inhibition During Voluntary Hypoventilation by Alexei Y. Bagrov, Olga V. Fedorova,
Enhanced Effect of Combining Human Cardiac Stem Cells and Bone Marrow Mesenchymal Stem Cells to Reduce Infarct Size and to Restore Cardiac Function After.

Enhanced Effect of Combining Human Cardiac Stem Cells and Bone Marrow Mesenchymal Stem Cells to Reduce Infarct Size and to Restore Cardiac Function After.
by Michael D. Elliott, Ajoy Kapoor, Michele A. Parker, Dixon B

by Michael D. Elliott, Ajoy Kapoor, Michele A. Parker, Dixon B
Driving Times and Distances to Hospitals With Percutaneous Coronary Intervention in the United States by Brahmajee K. Nallamothu, Eric R. Bates, Yongfei.

Driving Times and Distances to Hospitals With Percutaneous Coronary Intervention in the United States by Brahmajee K. Nallamothu, Eric R. Bates, Yongfei.
Copyright © 2004 American Medical Association. All rights reserved.

Copyright © 2004 American Medical Association. All rights reserved.
Circ Cardiovasc Qual Outcomes

Circ Cardiovasc Qual Outcomes

Similar presentations

Ads by Google